avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SMAD1
|
ENSG00000170365.10 | SMAD1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SMAD1 | hg38_v1_chr4_+_145481845_145481871, hg38_v1_chr4_+_145482761_145482820 | -0.52 | 1.3e-16 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_-_105771405 | 147.99 |
ENST00000641136.1
ENST00000390551.6 |
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
chr14_-_105644790 | 124.35 |
ENST00000641095.1
ENST00000390545.3 |
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
chr14_-_105626066 | 112.60 |
ENST00000641978.1
ENST00000390543.3 |
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
chr6_+_33080445 | 89.61 |
ENST00000428835.5
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr22_+_22895368 | 85.51 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 |
chr6_+_33075952 | 83.33 |
ENST00000418931.7
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr19_+_49335396 | 80.83 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr22_+_22899481 | 77.44 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr14_-_105743032 | 72.21 |
ENST00000390548.6
ENST00000390549.6 ENST00000390542.6 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
chrX_-_107775951 | 71.76 |
ENST00000315660.8
ENST00000372384.6 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family member 3 |
chr22_+_22904850 | 62.61 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr2_-_89160329 | 58.64 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
chr2_-_88992903 | 55.90 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chrX_-_107775740 | 54.24 |
ENST00000372383.9
|
TSC22D3
|
TSC22 domain family member 3 |
chr2_+_90038848 | 49.00 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
chr6_-_33080710 | 48.57 |
ENST00000419277.5
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr9_+_136980211 | 48.16 |
ENST00000444903.2
|
PTGDS
|
prostaglandin D2 synthase |
chr4_-_1208825 | 45.62 |
ENST00000511679.5
ENST00000617421.4 |
SPON2
|
spondin 2 |
chr14_-_106507476 | 40.26 |
ENST00000390621.3
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr14_-_105708627 | 40.22 |
ENST00000641837.1
ENST00000390547.3 |
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr6_+_31615984 | 39.35 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
chr11_+_1870252 | 38.37 |
ENST00000612798.4
|
LSP1
|
lymphocyte specific protein 1 |
chr4_-_1172575 | 37.59 |
ENST00000290902.10
|
SPON2
|
spondin 2 |
chr6_-_31272069 | 37.52 |
ENST00000415537.1
ENST00000376228.9 ENST00000383329.7 |
HLA-C
|
major histocompatibility complex, class I, C |
chr21_-_44910630 | 37.51 |
ENST00000320216.10
ENST00000397852.5 |
ITGB2
|
integrin subunit beta 2 |
chr19_+_1067493 | 36.53 |
ENST00000586866.5
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr6_-_31582415 | 35.82 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
chr22_+_22697789 | 35.37 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr22_-_19525369 | 34.98 |
ENST00000403084.1
ENST00000413119.2 |
CLDN5
|
claudin 5 |
chr4_-_1173168 | 34.61 |
ENST00000514490.5
ENST00000431380.5 ENST00000503765.5 |
SPON2
|
spondin 2 |
chr6_+_31615215 | 34.23 |
ENST00000337917.11
ENST00000376059.8 |
AIF1
|
allograft inflammatory factor 1 |
chr11_+_1870150 | 34.14 |
ENST00000429923.5
ENST00000418975.1 ENST00000406638.6 |
LSP1
|
lymphocyte specific protein 1 |
chr16_+_30472733 | 34.11 |
ENST00000356798.11
ENST00000433423.2 |
ITGAL
|
integrin subunit alpha L |
chr18_-_50287816 | 33.37 |
ENST00000589548.6
ENST00000673786.1 |
CXXC1
|
CXXC finger protein 1 |
chr2_+_90069662 | 33.00 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
chr2_-_89040745 | 32.75 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr6_+_32637419 | 32.51 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr4_-_56656507 | 32.39 |
ENST00000381255.7
ENST00000317745.11 ENST00000555760.6 ENST00000556614.6 |
HOPX
|
HOP homeobox |
chr16_+_172869 | 31.83 |
ENST00000251595.11
ENST00000397806.1 ENST00000484216.1 |
HBA2
|
hemoglobin subunit alpha 2 |
chr1_-_30757767 | 31.74 |
ENST00000294507.4
|
LAPTM5
|
lysosomal protein transmembrane 5 |
chr13_+_30735523 | 31.71 |
ENST00000380490.5
|
ALOX5AP
|
arachidonate 5-lipoxygenase activating protein |
chr12_-_14951106 | 31.49 |
ENST00000541644.5
ENST00000545895.5 |
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr19_+_1067144 | 31.42 |
ENST00000313093.7
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr12_-_108633864 | 30.89 |
ENST00000550948.2
|
SELPLG
|
selectin P ligand |
chr9_+_136977496 | 30.71 |
ENST00000371625.8
ENST00000457950.5 |
PTGDS
|
prostaglandin D2 synthase |
chr11_+_121590388 | 30.43 |
ENST00000527934.1
|
SORL1
|
sortilin related receptor 1 |
chr22_+_22887780 | 29.94 |
ENST00000532223.2
ENST00000526893.6 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda like polypeptide 5 |
chr21_-_44920855 | 29.66 |
ENST00000397854.7
|
ITGB2
|
integrin subunit beta 2 |
chr19_+_45469841 | 29.66 |
ENST00000592811.5
ENST00000586615.5 |
FOSB
|
FosB proto-oncogene, AP-1 transcription factor subunit |
chr6_+_29942523 | 29.24 |
ENST00000376809.10
ENST00000376802.2 ENST00000638375.1 |
HLA-A
|
major histocompatibility complex, class I, A |
chr6_+_31587268 | 28.28 |
ENST00000396101.7
ENST00000490742.5 |
LST1
|
leukocyte specific transcript 1 |
chr19_+_1077394 | 27.97 |
ENST00000590577.2
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr14_-_105856183 | 27.74 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
chr2_+_89862438 | 27.11 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr7_+_74209386 | 27.11 |
ENST00000344995.9
|
LAT2
|
linker for activation of T cells family member 2 |
chr2_-_89143133 | 26.98 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
chr17_+_39927724 | 26.86 |
ENST00000377924.6
ENST00000578802.1 ENST00000578478.1 ENST00000582263.1 |
LRRC3C
ENSG00000264968.1
|
leucine rich repeat containing 3C novel transcript |
chr11_+_2302119 | 26.67 |
ENST00000381121.7
|
TSPAN32
|
tetraspanin 32 |
chr12_+_6946468 | 26.10 |
ENST00000543115.5
ENST00000399448.5 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
chr13_+_30713477 | 25.56 |
ENST00000617770.4
|
ALOX5AP
|
arachidonate 5-lipoxygenase activating protein |
chr11_-_2301859 | 25.17 |
ENST00000456145.2
ENST00000381153.8 |
C11orf21
|
chromosome 11 open reading frame 21 |
chr2_+_89851723 | 24.99 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr14_-_105940235 | 24.93 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
chr1_+_27879638 | 24.92 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
chr2_-_88979016 | 24.62 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr2_+_238138661 | 24.46 |
ENST00000409223.2
|
KLHL30
|
kelch like family member 30 |
chr18_-_50287570 | 24.35 |
ENST00000586837.1
ENST00000412036.6 ENST00000589940.5 ENST00000587396.1 ENST00000591474.5 ENST00000285106.11 |
CXXC1
|
CXXC finger protein 1 |
chr2_+_68365274 | 24.31 |
ENST00000234313.8
|
PLEK
|
pleckstrin |
chr22_+_22734577 | 23.93 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr2_-_89100352 | 23.78 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr19_+_41877267 | 23.65 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
chr1_+_161215242 | 23.49 |
ENST00000367992.7
ENST00000289902.2 |
FCER1G
|
Fc fragment of IgE receptor Ig |
chr11_-_5234475 | 23.44 |
ENST00000292901.7
ENST00000650601.1 ENST00000417377.1 |
HBD
|
hemoglobin subunit delta |
chr22_+_22431949 | 23.14 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
chr2_-_136118142 | 23.00 |
ENST00000241393.4
|
CXCR4
|
C-X-C motif chemokine receptor 4 |
chr17_-_64390852 | 22.85 |
ENST00000563924.6
|
PECAM1
|
platelet and endothelial cell adhesion molecule 1 |
chr17_-_82317589 | 22.81 |
ENST00000312648.8
|
CD7
|
CD7 molecule |
chr6_+_32741382 | 22.74 |
ENST00000374940.4
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
chr22_+_22822658 | 22.36 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr6_-_25042003 | 22.36 |
ENST00000510784.8
|
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr14_-_94390650 | 22.33 |
ENST00000449399.7
ENST00000404814.8 |
SERPINA1
|
serpin family A member 1 |
chr17_-_82317523 | 22.32 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.5 ENST00000582480.1 |
CD7
|
CD7 molecule |
chr16_+_3065297 | 22.13 |
ENST00000325568.9
|
IL32
|
interleukin 32 |
chr1_+_152663378 | 22.00 |
ENST00000368784.2
|
LCE2D
|
late cornified envelope 2D |
chr16_+_3065311 | 21.76 |
ENST00000534507.5
ENST00000613483.4 ENST00000531965.5 ENST00000396887.7 |
IL32
|
interleukin 32 |
chr2_-_89010515 | 21.74 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr19_+_39406831 | 21.66 |
ENST00000597629.3
ENST00000594442.2 ENST00000594045.2 |
ZFP36
|
ZFP36 ring finger protein |
chr14_-_95714088 | 21.62 |
ENST00000556450.5
|
TCL1A
|
TCL1 family AKT coactivator A |
chr11_+_314010 | 21.56 |
ENST00000680699.1
ENST00000681938.1 ENST00000679380.1 ENST00000680938.1 ENST00000408968.4 ENST00000681180.1 ENST00000681426.1 ENST00000680696.1 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr6_-_24877262 | 21.43 |
ENST00000378023.8
ENST00000540914.5 |
RIPOR2
|
RHO family interacting cell polarization regulator 2 |
chr4_-_56656448 | 21.42 |
ENST00000553379.6
|
HOPX
|
HOP homeobox |
chr10_+_45374204 | 21.20 |
ENST00000374391.7
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr22_+_22758698 | 21.15 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
chr6_-_31357171 | 21.11 |
ENST00000412585.7
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
chr6_+_30489501 | 21.07 |
ENST00000376630.5
|
HLA-E
|
major histocompatibility complex, class I, E |
chr2_+_90159840 | 21.03 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_+_87338511 | 21.02 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
chr11_+_2301987 | 20.91 |
ENST00000612299.4
ENST00000182290.9 |
TSPAN32
|
tetraspanin 32 |
chr3_-_41961989 | 20.83 |
ENST00000420927.5
ENST00000301831.9 ENST00000414606.1 |
ULK4
|
unc-51 like kinase 4 |
chr2_+_90172802 | 20.76 |
ENST00000390277.3
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
chr7_+_74209989 | 20.75 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
chr14_-_95714146 | 20.60 |
ENST00000554012.5
|
TCL1A
|
TCL1 family AKT coactivator A |
chr14_-_95714114 | 20.57 |
ENST00000402399.6
ENST00000555202.1 |
TCL1A
|
TCL1 family AKT coactivator A |
chr22_-_37149900 | 20.48 |
ENST00000216223.10
|
IL2RB
|
interleukin 2 receptor subunit beta |
chr3_-_121660892 | 20.37 |
ENST00000428394.6
ENST00000314583.8 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr1_-_161631152 | 20.29 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
chr20_-_23086316 | 20.26 |
ENST00000246006.5
|
CD93
|
CD93 molecule |
chr11_+_1868673 | 20.22 |
ENST00000405957.6
|
LSP1
|
lymphocyte specific protein 1 |
chr14_-_106658251 | 20.22 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr2_+_90234809 | 20.02 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
chr19_+_44914588 | 20.00 |
ENST00000592535.6
|
APOC1
|
apolipoprotein C1 |
chr1_+_153357846 | 19.94 |
ENST00000368738.4
|
S100A9
|
S100 calcium binding protein A9 |
chr2_-_86790825 | 19.81 |
ENST00000409781.1
ENST00000352580.7 |
CD8A
|
CD8a molecule |
chr6_+_32637396 | 19.81 |
ENST00000395363.5
ENST00000496318.5 ENST00000343139.11 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr16_+_30472700 | 19.75 |
ENST00000358164.9
|
ITGAL
|
integrin subunit alpha L |
chr14_-_94390667 | 19.74 |
ENST00000557492.5
ENST00000355814.8 ENST00000437397.5 ENST00000448921.5 ENST00000393088.8 |
SERPINA1
|
serpin family A member 1 |
chr22_+_36863091 | 19.73 |
ENST00000650698.1
|
NCF4
|
neutrophil cytosolic factor 4 |
chr1_+_32274111 | 19.59 |
ENST00000619559.4
ENST00000461712.6 ENST00000373562.7 ENST00000477031.6 ENST00000373557.6 ENST00000333070.4 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
chr1_-_202159977 | 19.42 |
ENST00000367279.8
|
PTPN7
|
protein tyrosine phosphatase non-receptor type 7 |
chr14_-_106185387 | 19.41 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
chr19_-_54280498 | 19.38 |
ENST00000391746.5
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
chr10_+_38010617 | 19.29 |
ENST00000307441.13
ENST00000374618.7 ENST00000628825.2 ENST00000458705.6 ENST00000432900.7 ENST00000469037.2 |
ZNF33A
|
zinc finger protein 33A |
chr6_-_73452124 | 19.19 |
ENST00000680833.1
|
CGAS
|
cyclic GMP-AMP synthase |
chr14_+_22547495 | 19.07 |
ENST00000611116.2
|
TRAC
|
T cell receptor alpha constant |
chr5_-_150113344 | 18.97 |
ENST00000286301.7
ENST00000511344.1 |
CSF1R
|
colony stimulating factor 1 receptor |
chr19_+_1067272 | 18.84 |
ENST00000590214.5
|
ARHGAP45
|
Rho GTPase activating protein 45 |
chr11_-_5227063 | 18.80 |
ENST00000335295.4
ENST00000485743.1 ENST00000647020.1 |
HBB
|
hemoglobin subunit beta |
chr2_-_89320146 | 18.71 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr11_+_308408 | 18.66 |
ENST00000399815.2
|
ENSG00000288681.1
|
novel protein |
chr11_+_2400488 | 18.56 |
ENST00000380996.9
ENST00000380992.5 ENST00000333256.11 ENST00000437110.5 ENST00000435795.5 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr2_-_86790900 | 18.50 |
ENST00000283635.8
|
CD8A
|
CD8a molecule |
chr14_-_106715166 | 18.49 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr1_+_12019460 | 18.46 |
ENST00000235332.6
|
MIIP
|
migration and invasion inhibitory protein |
chr6_-_166956561 | 18.44 |
ENST00000366855.10
|
RNASET2
|
ribonuclease T2 |
chr19_-_35740535 | 18.42 |
ENST00000591748.1
|
IGFLR1
|
IGF like family receptor 1 |
chr19_+_47309853 | 18.42 |
ENST00000355085.4
|
C5AR1
|
complement C5a receptor 1 |
chr16_+_3065348 | 18.36 |
ENST00000529699.5
ENST00000526464.6 ENST00000440815.7 ENST00000529550.5 |
IL32
|
interleukin 32 |
chr6_+_31586835 | 18.09 |
ENST00000211921.11
|
LST1
|
leukocyte specific transcript 1 |
chr22_+_22327298 | 18.09 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr14_-_94390614 | 18.07 |
ENST00000553327.5
ENST00000556955.5 ENST00000557118.5 ENST00000440909.5 |
SERPINA1
|
serpin family A member 1 |
chr12_+_6789508 | 18.04 |
ENST00000011653.9
ENST00000541982.5 ENST00000539492.1 |
CD4
|
CD4 molecule |
chr19_-_3801791 | 18.04 |
ENST00000590849.1
ENST00000395045.6 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr7_-_150800320 | 17.96 |
ENST00000492607.5
ENST00000326442.10 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
chr5_-_170297746 | 17.71 |
ENST00000046794.10
|
LCP2
|
lymphocyte cytosolic protein 2 |
chr11_-_61917490 | 17.53 |
ENST00000394836.7
|
RAB3IL1
|
RAB3A interacting protein like 1 |
chr14_-_106422175 | 17.53 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr9_+_136979042 | 17.49 |
ENST00000446677.2
|
PTGDS
|
prostaglandin D2 synthase |
chr22_+_22792485 | 17.37 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr19_+_18173804 | 17.36 |
ENST00000407280.4
|
IFI30
|
IFI30 lysosomal thiol reductase |
chr14_-_106737547 | 17.28 |
ENST00000632209.1
|
IGHV1-69-2
|
immunoglobulin heavy variable 1-69-2 |
chr15_+_81299416 | 17.27 |
ENST00000558332.3
|
IL16
|
interleukin 16 |
chr12_+_6951345 | 17.23 |
ENST00000318974.14
ENST00000541698.5 ENST00000542462.1 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
chr1_-_169711603 | 17.16 |
ENST00000236147.6
ENST00000650983.1 |
SELL
|
selectin L |
chr19_-_51372640 | 17.11 |
ENST00000600427.5
ENST00000221978.10 |
NKG7
|
natural killer cell granule protein 7 |
chr15_+_81296913 | 17.10 |
ENST00000394652.6
|
IL16
|
interleukin 16 |
chr16_-_66552460 | 17.07 |
ENST00000678015.1
ENST00000569718.6 ENST00000678314.1 ENST00000562484.2 |
TK2
|
thymidine kinase 2 |
chr16_+_1240698 | 17.01 |
ENST00000561736.2
ENST00000338844.8 ENST00000461509.6 |
TPSAB1
|
tryptase alpha/beta 1 |
chr12_+_120725796 | 16.88 |
ENST00000242592.9
ENST00000411593.2 |
ACADS
|
acyl-CoA dehydrogenase short chain |
chr10_+_80408503 | 16.74 |
ENST00000606162.6
|
PRXL2A
|
peroxiredoxin like 2A |
chr15_-_78944985 | 16.57 |
ENST00000615999.5
ENST00000677789.1 ENST00000676880.1 ENST00000677936.1 ENST00000220166.10 ENST00000677810.1 ENST00000678644.1 ENST00000677534.1 ENST00000677316.1 |
CTSH
|
cathepsin H |
chr15_-_21742799 | 16.52 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr3_+_88059231 | 16.49 |
ENST00000636215.2
|
ZNF654
|
zinc finger protein 654 |
chr3_-_50338226 | 16.46 |
ENST00000395126.7
|
RASSF1
|
Ras association domain family member 1 |
chr10_+_11165475 | 16.43 |
ENST00000609692.5
ENST00000354897.3 |
CELF2
|
CUGBP Elav-like family member 2 |
chr19_-_51372269 | 16.43 |
ENST00000593572.5
ENST00000595157.1 |
NKG7
|
natural killer cell granule protein 7 |
chr15_+_88638947 | 16.37 |
ENST00000559876.2
|
ISG20
|
interferon stimulated exonuclease gene 20 |
chrX_+_71366290 | 16.31 |
ENST00000683782.1
ENST00000423759.6 |
TAF1
|
TATA-box binding protein associated factor 1 |
chrX_-_107777038 | 16.30 |
ENST00000480691.2
ENST00000506081.5 ENST00000514426.1 |
TSC22D3
|
TSC22 domain family member 3 |
chr18_+_79679775 | 16.29 |
ENST00000613122.5
ENST00000075430.11 |
CTDP1
|
CTD phosphatase subunit 1 |
chr22_+_22922594 | 16.26 |
ENST00000390331.3
|
IGLC7
|
immunoglobulin lambda constant 7 |
chr10_+_45374167 | 16.07 |
ENST00000542434.5
|
ALOX5
|
arachidonate 5-lipoxygenase |
chr11_+_121576760 | 15.96 |
ENST00000532694.5
ENST00000534286.5 |
SORL1
|
sortilin related receptor 1 |
chr5_-_42825884 | 15.95 |
ENST00000506577.5
|
SELENOP
|
selenoprotein P |
chr2_+_68774782 | 15.92 |
ENST00000409030.7
ENST00000409220.5 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr13_+_41457543 | 15.89 |
ENST00000379359.4
|
RGCC
|
regulator of cell cycle |
chr14_-_106025628 | 15.88 |
ENST00000631943.1
|
IGHV7-4-1
|
immunoglobulin heavy variable 7-4-1 |
chr14_-_106277039 | 15.87 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
chr2_-_89213917 | 15.78 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr2_+_90082635 | 15.77 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr1_-_27635176 | 15.75 |
ENST00000374005.8
|
FGR
|
FGR proto-oncogene, Src family tyrosine kinase |
chr9_-_134917872 | 15.74 |
ENST00000616356.4
ENST00000371806.4 |
FCN1
|
ficolin 1 |
chr1_+_192575765 | 15.72 |
ENST00000469578.2
ENST00000367459.8 |
RGS1
|
regulator of G protein signaling 1 |
chr19_+_8413270 | 15.70 |
ENST00000381035.8
ENST00000595142.5 ENST00000601724.5 ENST00000601283.5 ENST00000215555.7 ENST00000595213.1 |
MARCHF2
|
membrane associated ring-CH-type finger 2 |
chr19_-_35908247 | 15.70 |
ENST00000585901.6
ENST00000544690.6 ENST00000424586.7 ENST00000262629.9 ENST00000589517.1 |
TYROBP
|
transmembrane immune signaling adaptor TYROBP |
chr1_+_152675295 | 15.64 |
ENST00000368783.1
|
LCE2C
|
late cornified envelope 2C |
chrX_+_47078330 | 15.60 |
ENST00000457380.5
|
RGN
|
regucalcin |
chr6_-_166956537 | 15.60 |
ENST00000508775.6
|
RNASET2
|
ribonuclease T2 |
chr15_-_19988117 | 15.57 |
ENST00000558565.2
|
IGHV3OR15-7
|
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr17_-_17972374 | 15.50 |
ENST00000318094.14
ENST00000540946.5 ENST00000379504.8 ENST00000542206.5 ENST00000395739.8 ENST00000581396.5 ENST00000535933.5 ENST00000579586.1 |
TOM1L2
|
target of myb1 like 2 membrane trafficking protein |
chr5_+_55102635 | 15.49 |
ENST00000274306.7
|
GZMA
|
granzyme A |
chr12_-_3873346 | 15.47 |
ENST00000427057.6
|
PARP11
|
poly(ADP-ribose) polymerase family member 11 |
chr11_-_67437670 | 15.42 |
ENST00000326294.4
|
PTPRCAP
|
protein tyrosine phosphatase receptor type C associated protein |
chr9_-_94639473 | 15.41 |
ENST00000375326.9
|
FBP1
|
fructose-bisphosphatase 1 |
chr16_+_33802683 | 15.37 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
chr16_+_3065380 | 15.36 |
ENST00000551122.5
ENST00000548807.5 ENST00000528163.6 |
IL32
|
interleukin 32 |
chr10_-_133276836 | 15.32 |
ENST00000415217.7
|
ADAM8
|
ADAM metallopeptidase domain 8 |
chr15_-_21718245 | 15.29 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
chr19_-_54364863 | 15.23 |
ENST00000348231.8
|
LAIR1
|
leukocyte associated immunoglobulin like receptor 1 |
chr14_-_105588322 | 15.20 |
ENST00000497872.4
ENST00000390539.2 |
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
chrX_-_153926220 | 15.06 |
ENST00000370016.5
|
ARHGAP4
|
Rho GTPase activating protein 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.6 | 149.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
15.5 | 46.4 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
13.7 | 137.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
13.7 | 68.5 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
13.7 | 1027.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
12.8 | 64.1 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
12.2 | 36.7 | GO:0002892 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) |
11.8 | 129.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
11.7 | 58.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
10.8 | 43.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
10.6 | 42.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
10.5 | 31.5 | GO:0071461 | cellular response to redox state(GO:0071461) |
10.3 | 10.3 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
10.1 | 30.3 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
10.1 | 80.5 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
10.0 | 39.9 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
9.8 | 39.3 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
9.4 | 37.6 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
9.3 | 46.3 | GO:0072535 | tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
9.2 | 27.5 | GO:0030185 | nitric oxide transport(GO:0030185) |
9.0 | 36.2 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
9.0 | 9.0 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
8.9 | 26.7 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
8.9 | 8.9 | GO:1903004 | regulation of protein K63-linked deubiquitination(GO:1903004) positive regulation of protein K63-linked deubiquitination(GO:1903006) |
8.9 | 26.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
8.6 | 25.8 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
8.4 | 67.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
8.3 | 24.8 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
8.1 | 32.4 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
8.1 | 32.3 | GO:1903631 | regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
7.9 | 71.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
7.6 | 22.9 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
7.6 | 30.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
7.4 | 29.6 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
7.4 | 22.1 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
7.2 | 136.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
7.1 | 21.4 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
6.8 | 6.8 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
6.8 | 6.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
6.8 | 635.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
6.7 | 20.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
6.5 | 13.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
6.5 | 25.9 | GO:0002357 | defense response to tumor cell(GO:0002357) |
6.5 | 45.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
6.4 | 6.4 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
6.2 | 24.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
6.2 | 24.7 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
6.1 | 12.3 | GO:1905237 | response to cyclosporin A(GO:1905237) |
6.1 | 61.0 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
6.1 | 6.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
5.9 | 17.8 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
5.8 | 11.5 | GO:0001812 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
5.7 | 22.8 | GO:0072011 | diapedesis(GO:0050904) glomerular endothelium development(GO:0072011) |
5.6 | 39.2 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
5.5 | 16.6 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
5.5 | 16.4 | GO:2000754 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
5.4 | 16.2 | GO:0002818 | intracellular defense response(GO:0002818) |
5.4 | 16.2 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
5.3 | 37.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
5.3 | 15.9 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
5.2 | 20.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
5.2 | 5.2 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
5.2 | 31.0 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
5.1 | 106.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
5.0 | 5.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
4.9 | 4.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
4.9 | 4.9 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
4.9 | 4.9 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
4.9 | 14.6 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
4.8 | 24.1 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
4.5 | 17.9 | GO:0050757 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
4.4 | 22.0 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
4.4 | 13.2 | GO:0061011 | hepatic duct development(GO:0061011) |
4.4 | 13.2 | GO:0051673 | pore formation in membrane of other organism(GO:0035915) membrane disruption in other organism(GO:0051673) |
4.3 | 17.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
4.3 | 4.3 | GO:0060290 | transdifferentiation(GO:0060290) |
4.3 | 12.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
4.2 | 12.7 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
4.2 | 12.6 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
4.2 | 8.4 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
4.2 | 12.5 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
4.2 | 4.2 | GO:0070662 | mast cell proliferation(GO:0070662) |
4.1 | 8.2 | GO:0071464 | cellular response to hydrostatic pressure(GO:0071464) |
4.1 | 4.1 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
4.1 | 4.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
4.1 | 16.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
4.0 | 24.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
4.0 | 60.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
4.0 | 15.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.9 | 15.7 | GO:0019082 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
3.9 | 11.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
3.9 | 3.9 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
3.8 | 11.5 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
3.8 | 23.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
3.8 | 15.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.8 | 15.2 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
3.8 | 7.6 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
3.8 | 3.8 | GO:0032058 | positive regulation of translation in response to stress(GO:0032056) positive regulation of translational initiation in response to stress(GO:0032058) |
3.8 | 3.8 | GO:0036245 | cellular response to menadione(GO:0036245) |
3.7 | 22.4 | GO:0038016 | insulin receptor internalization(GO:0038016) |
3.7 | 14.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
3.7 | 11.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
3.7 | 22.0 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
3.6 | 10.9 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
3.6 | 47.2 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
3.6 | 79.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
3.6 | 10.7 | GO:1902528 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
3.5 | 14.2 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
3.5 | 3.5 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
3.5 | 21.1 | GO:0019732 | antifungal humoral response(GO:0019732) |
3.5 | 20.9 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
3.5 | 13.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
3.4 | 10.3 | GO:0071529 | cementum mineralization(GO:0071529) |
3.4 | 34.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
3.4 | 17.1 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
3.3 | 6.7 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
3.3 | 10.0 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
3.3 | 10.0 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
3.3 | 13.3 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
3.3 | 9.9 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
3.3 | 6.6 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
3.3 | 9.9 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
3.3 | 13.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.3 | 3.3 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
3.3 | 32.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
3.3 | 3.3 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
3.3 | 9.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
3.3 | 6.5 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
3.2 | 19.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
3.2 | 376.7 | GO:0031295 | T cell costimulation(GO:0031295) |
3.2 | 25.3 | GO:0015705 | iodide transport(GO:0015705) |
3.2 | 31.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.2 | 25.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
3.1 | 6.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
3.1 | 9.4 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
3.1 | 6.2 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
3.1 | 12.4 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
3.1 | 3.1 | GO:0071910 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
3.1 | 24.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
3.1 | 3.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
3.1 | 9.2 | GO:0034769 | basement membrane disassembly(GO:0034769) |
3.0 | 3.0 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
3.0 | 3.0 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
3.0 | 9.0 | GO:0009720 | detection of hormone stimulus(GO:0009720) detection of endogenous stimulus(GO:0009726) |
3.0 | 9.0 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
3.0 | 18.0 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
3.0 | 8.9 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
3.0 | 3.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
3.0 | 53.4 | GO:0015671 | oxygen transport(GO:0015671) |
2.9 | 5.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.9 | 29.1 | GO:0006116 | NADH oxidation(GO:0006116) |
2.9 | 14.4 | GO:0032494 | response to peptidoglycan(GO:0032494) |
2.9 | 20.2 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.9 | 2.9 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
2.9 | 20.0 | GO:0015811 | L-cystine transport(GO:0015811) |
2.8 | 14.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
2.8 | 8.5 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
2.8 | 2.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
2.8 | 5.6 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
2.8 | 16.6 | GO:0043366 | beta selection(GO:0043366) |
2.8 | 19.4 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
2.8 | 2.8 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
2.7 | 2.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
2.7 | 8.2 | GO:0032954 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
2.7 | 10.9 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
2.7 | 19.0 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
2.7 | 8.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
2.7 | 8.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
2.7 | 10.7 | GO:0035900 | response to isolation stress(GO:0035900) |
2.7 | 8.0 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
2.6 | 13.2 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
2.6 | 5.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
2.6 | 76.3 | GO:0045730 | respiratory burst(GO:0045730) |
2.6 | 13.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
2.6 | 18.2 | GO:0045007 | depurination(GO:0045007) |
2.6 | 20.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
2.6 | 7.8 | GO:0060366 | subpallium cell proliferation in forebrain(GO:0022012) lateral ganglionic eminence cell proliferation(GO:0022018) lambdoid suture morphogenesis(GO:0060366) sagittal suture morphogenesis(GO:0060367) anterior semicircular canal development(GO:0060873) lateral semicircular canal development(GO:0060875) |
2.6 | 2.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
2.6 | 5.2 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
2.6 | 7.7 | GO:1901097 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of autophagosome maturation(GO:1901097) |
2.5 | 17.6 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.5 | 7.5 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) positive regulation of fibril organization(GO:1902905) |
2.5 | 12.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
2.5 | 5.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
2.5 | 138.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
2.5 | 12.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
2.4 | 4.9 | GO:0071104 | response to interleukin-9(GO:0071104) |
2.4 | 9.5 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
2.4 | 33.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
2.4 | 21.3 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
2.4 | 7.1 | GO:0002384 | hepatic immune response(GO:0002384) |
2.4 | 4.7 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
2.3 | 16.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
2.3 | 7.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.3 | 32.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
2.3 | 11.7 | GO:1901563 | response to camptothecin(GO:1901563) |
2.3 | 14.0 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
2.3 | 2.3 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
2.3 | 4.7 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
2.3 | 4.7 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
2.3 | 9.3 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
2.3 | 9.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
2.3 | 2.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.3 | 9.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.3 | 4.6 | GO:0070842 | aggresome assembly(GO:0070842) |
2.3 | 27.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
2.3 | 2.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
2.3 | 13.8 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
2.3 | 4.6 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
2.3 | 6.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
2.3 | 4.6 | GO:0060374 | mast cell differentiation(GO:0060374) |
2.3 | 6.9 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
2.3 | 20.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.3 | 11.3 | GO:0045023 | G0 to G1 transition(GO:0045023) |
2.3 | 4.5 | GO:0036269 | swimming behavior(GO:0036269) |
2.2 | 15.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
2.2 | 6.7 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
2.2 | 9.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.2 | 49.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
2.2 | 6.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.2 | 8.9 | GO:0071918 | urea transmembrane transport(GO:0071918) |
2.2 | 13.3 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
2.2 | 4.4 | GO:0015840 | urea transport(GO:0015840) |
2.2 | 10.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
2.2 | 2.2 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
2.2 | 47.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
2.2 | 19.6 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
2.2 | 6.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
2.2 | 15.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
2.2 | 6.5 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
2.1 | 17.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.1 | 6.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
2.1 | 21.3 | GO:0018377 | protein myristoylation(GO:0018377) |
2.1 | 4.2 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
2.1 | 14.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
2.1 | 10.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
2.1 | 2.1 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
2.1 | 14.5 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
2.0 | 8.1 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
2.0 | 6.1 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
2.0 | 26.3 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
2.0 | 4.0 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
2.0 | 2.0 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
2.0 | 9.9 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
2.0 | 19.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
2.0 | 5.9 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
1.9 | 5.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
1.9 | 13.5 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.9 | 5.7 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.9 | 3.8 | GO:1903413 | cellular response to bile acid(GO:1903413) |
1.9 | 32.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
1.9 | 34.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.9 | 1.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
1.9 | 20.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.9 | 5.6 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
1.9 | 31.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
1.8 | 5.5 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.8 | 9.2 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
1.8 | 5.5 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
1.8 | 29.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.8 | 5.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.8 | 3.6 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
1.8 | 112.5 | GO:0006968 | cellular defense response(GO:0006968) |
1.8 | 1.8 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
1.8 | 7.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.8 | 7.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
1.8 | 257.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.8 | 5.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
1.8 | 7.1 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.8 | 1.8 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
1.8 | 1.8 | GO:0046110 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
1.8 | 3.5 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
1.8 | 8.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.8 | 8.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
1.8 | 7.0 | GO:0043335 | protein unfolding(GO:0043335) |
1.7 | 7.0 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.7 | 5.2 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
1.7 | 5.2 | GO:0070269 | pyroptosis(GO:0070269) |
1.7 | 3.4 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
1.7 | 20.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
1.7 | 6.9 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
1.7 | 6.9 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
1.7 | 12.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.7 | 20.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
1.7 | 15.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.7 | 13.6 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
1.7 | 1.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
1.7 | 11.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.7 | 6.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
1.6 | 6.6 | GO:1903182 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
1.6 | 14.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
1.6 | 8.2 | GO:0044245 | polysaccharide digestion(GO:0044245) |
1.6 | 22.9 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
1.6 | 1.6 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) |
1.6 | 3.3 | GO:2000583 | regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
1.6 | 9.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.6 | 3.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
1.6 | 3.2 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
1.6 | 6.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.6 | 8.0 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
1.6 | 8.0 | GO:0072708 | response to sorbitol(GO:0072708) |
1.6 | 38.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.6 | 11.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.6 | 6.4 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.6 | 8.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
1.6 | 14.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.6 | 4.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
1.6 | 22.1 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
1.6 | 6.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.6 | 10.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
1.6 | 4.7 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
1.6 | 3.1 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.6 | 9.4 | GO:0007000 | nucleolus organization(GO:0007000) |
1.6 | 1.6 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
1.6 | 7.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
1.5 | 3.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
1.5 | 1.5 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.5 | 6.2 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
1.5 | 3.1 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
1.5 | 9.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.5 | 6.1 | GO:0030910 | optic placode formation(GO:0001743) olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
1.5 | 12.2 | GO:0001554 | luteolysis(GO:0001554) |
1.5 | 7.6 | GO:0030242 | pexophagy(GO:0030242) |
1.5 | 4.6 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
1.5 | 6.0 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
1.5 | 3.0 | GO:0002215 | defense response to nematode(GO:0002215) |
1.5 | 1.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
1.5 | 3.0 | GO:0061056 | sclerotome development(GO:0061056) |
1.5 | 4.4 | GO:0033700 | phospholipid efflux(GO:0033700) |
1.5 | 4.4 | GO:1905063 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) regulation of vascular smooth muscle cell differentiation(GO:1905063) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) |
1.5 | 4.4 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
1.5 | 11.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.5 | 4.4 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
1.5 | 4.4 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.5 | 14.6 | GO:0007320 | insemination(GO:0007320) |
1.4 | 8.7 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
1.4 | 10.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
1.4 | 4.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.4 | 8.6 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
1.4 | 1.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.4 | 7.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
1.4 | 11.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
1.4 | 7.1 | GO:2000870 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
1.4 | 5.6 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
1.4 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 9.8 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
1.4 | 2.8 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
1.4 | 22.3 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
1.4 | 9.7 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
1.4 | 5.6 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
1.4 | 19.5 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
1.4 | 4.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.4 | 13.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.4 | 6.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
1.4 | 4.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
1.4 | 55.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
1.4 | 6.9 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
1.4 | 2.7 | GO:0021780 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.3 | 2.7 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
1.3 | 18.9 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.3 | 5.4 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
1.3 | 5.4 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
1.3 | 1.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.3 | 5.3 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
1.3 | 2.7 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
1.3 | 13.3 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
1.3 | 6.6 | GO:0046457 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
1.3 | 7.9 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.3 | 4.0 | GO:1904640 | response to methionine(GO:1904640) |
1.3 | 2.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
1.3 | 69.9 | GO:0006953 | acute-phase response(GO:0006953) |
1.3 | 2.6 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
1.3 | 2.6 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
1.3 | 6.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
1.3 | 3.9 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.3 | 20.8 | GO:0032367 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
1.3 | 13.0 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.3 | 9.1 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.3 | 9.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
1.3 | 3.9 | GO:1904017 | cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.3 | 6.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
1.3 | 2.6 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
1.3 | 6.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.3 | 5.1 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
1.3 | 2.6 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) positive regulation of relaxation of cardiac muscle(GO:1901899) |
1.3 | 6.4 | GO:0048102 | autophagic cell death(GO:0048102) |
1.3 | 5.1 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
1.3 | 1.3 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
1.3 | 7.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.3 | 3.8 | GO:1903465 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.3 | 3.8 | GO:0018343 | protein farnesylation(GO:0018343) |
1.3 | 3.8 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
1.3 | 7.5 | GO:0033088 | immature T cell proliferation in thymus(GO:0033080) regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
1.3 | 5.0 | GO:0006477 | protein sulfation(GO:0006477) |
1.2 | 2.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
1.2 | 2.5 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
1.2 | 4.9 | GO:0009305 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
1.2 | 7.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
1.2 | 4.9 | GO:0015942 | formate metabolic process(GO:0015942) |
1.2 | 20.9 | GO:0097186 | amelogenesis(GO:0097186) |
1.2 | 3.7 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
1.2 | 8.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
1.2 | 4.9 | GO:0050957 | equilibrioception(GO:0050957) |
1.2 | 16.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.2 | 30.2 | GO:0006706 | steroid catabolic process(GO:0006706) |
1.2 | 2.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.2 | 2.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
1.2 | 10.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.2 | 15.3 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
1.2 | 16.5 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
1.2 | 4.7 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
1.2 | 3.5 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
1.2 | 10.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.2 | 9.4 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.2 | 65.6 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
1.2 | 12.9 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
1.2 | 5.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
1.2 | 8.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
1.2 | 3.5 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
1.2 | 54.5 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.2 | 3.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.1 | 14.9 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
1.1 | 4.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
1.1 | 8.0 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.1 | 2.3 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
1.1 | 3.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
1.1 | 3.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 6.8 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
1.1 | 5.6 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.1 | 1.1 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
1.1 | 2.3 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
1.1 | 18.0 | GO:0019835 | cytolysis(GO:0019835) |
1.1 | 19.1 | GO:0007398 | ectoderm development(GO:0007398) |
1.1 | 4.5 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
1.1 | 4.5 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.1 | 1.1 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
1.1 | 12.3 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
1.1 | 2.2 | GO:0015819 | lysine transport(GO:0015819) lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine transport(GO:1902022) L-lysine import into cell(GO:1903410) |
1.1 | 3.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.1 | 4.4 | GO:0033602 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) negative regulation of dopamine secretion(GO:0033602) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
1.1 | 2.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.1 | 10.0 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
1.1 | 3.3 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
1.1 | 4.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
1.1 | 2.2 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
1.1 | 5.5 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.1 | 9.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
1.1 | 3.3 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
1.1 | 3.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
1.1 | 1.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
1.1 | 1.1 | GO:0019376 | galactolipid catabolic process(GO:0019376) |
1.1 | 7.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
1.1 | 3.3 | GO:0009085 | lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
1.1 | 1.1 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
1.1 | 3.2 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.1 | 3.2 | GO:0051918 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) negative regulation of fibrinolysis(GO:0051918) |
1.1 | 1.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 5.3 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.1 | 2.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
1.1 | 10.7 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 2.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
1.1 | 29.8 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
1.1 | 4.2 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
1.1 | 2.1 | GO:1990637 | response to prolactin(GO:1990637) |
1.1 | 4.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
1.0 | 27.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.0 | 4.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
1.0 | 2.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.0 | 31.2 | GO:0097503 | sialylation(GO:0097503) |
1.0 | 2.1 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 6.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.0 | 4.1 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.0 | 4.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
1.0 | 6.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
1.0 | 9.2 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
1.0 | 6.1 | GO:0032445 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
1.0 | 2.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.0 | 4.1 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
1.0 | 4.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
1.0 | 5.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.0 | 5.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.0 | 9.1 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.0 | 1.0 | GO:0042737 | drug catabolic process(GO:0042737) |
1.0 | 6.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.0 | 10.1 | GO:0015074 | DNA integration(GO:0015074) |
1.0 | 3.0 | GO:0051941 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) regulation of calcium:sodium antiporter activity(GO:1903279) |
1.0 | 6.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.0 | 1.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.0 | 9.0 | GO:0006069 | ethanol oxidation(GO:0006069) |
1.0 | 3.0 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
1.0 | 3.9 | GO:0046618 | drug export(GO:0046618) |
1.0 | 17.7 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
1.0 | 1.0 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
1.0 | 3.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
1.0 | 19.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.0 | 4.8 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
1.0 | 7.7 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
1.0 | 1.9 | GO:0090135 | actin filament branching(GO:0090135) |
1.0 | 16.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.0 | 3.8 | GO:0007512 | adult heart development(GO:0007512) |
1.0 | 1.0 | GO:0000023 | maltose metabolic process(GO:0000023) |
1.0 | 17.2 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.0 | 5.7 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.0 | 6.7 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.0 | 7.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.9 | 2.8 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.9 | 4.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.9 | 2.8 | GO:0036233 | glycine import(GO:0036233) |
0.9 | 4.7 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
0.9 | 30.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.9 | 1.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.9 | 2.8 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.9 | 7.4 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.9 | 7.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.9 | 7.4 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.9 | 4.6 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.9 | 40.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.9 | 5.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.9 | 4.6 | GO:0035624 | receptor transactivation(GO:0035624) |
0.9 | 2.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.9 | 7.3 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.9 | 7.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.9 | 2.7 | GO:0021571 | rhombomere 5 development(GO:0021571) rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.9 | 3.6 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.9 | 5.4 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.9 | 1.8 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.9 | 14.3 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.9 | 2.7 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.9 | 4.4 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 4.4 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.9 | 6.2 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
0.9 | 4.4 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.9 | 9.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.9 | 4.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.9 | 2.6 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
0.9 | 2.6 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.9 | 47.9 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.9 | 5.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.9 | 28.6 | GO:0032570 | response to progesterone(GO:0032570) |
0.9 | 1.7 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.9 | 13.7 | GO:0042116 | macrophage activation(GO:0042116) |
0.9 | 13.7 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.9 | 6.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.9 | 1.7 | GO:0015740 | C4-dicarboxylate transport(GO:0015740) |
0.8 | 3.4 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.8 | 3.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.8 | 1.7 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 4.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.8 | 144.1 | GO:0002250 | adaptive immune response(GO:0002250) |
0.8 | 11.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.8 | 9.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.8 | 1.7 | GO:0001757 | somite specification(GO:0001757) |
0.8 | 1.7 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
0.8 | 14.8 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.8 | 4.9 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.8 | 19.7 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.8 | 2.5 | GO:1902988 | neurofibrillary tangle assembly(GO:1902988) |
0.8 | 7.3 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.8 | 1.6 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.8 | 4.9 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
0.8 | 0.8 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.8 | 1.6 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.8 | 21.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.8 | 5.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.8 | 7.3 | GO:0001675 | acrosome assembly(GO:0001675) |
0.8 | 8.0 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.8 | 7.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.8 | 3.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.8 | 4.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.8 | 7.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.8 | 8.0 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.8 | 11.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.8 | 10.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.8 | 2.4 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
0.8 | 8.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.8 | 3.2 | GO:0010157 | response to chlorate(GO:0010157) |
0.8 | 4.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.8 | 2.4 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.8 | 2.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.8 | 19.5 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.8 | 3.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 | 38.0 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.8 | 3.9 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.8 | 11.6 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.8 | 0.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.8 | 3.1 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.8 | 16.8 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.8 | 26.7 | GO:0010107 | potassium ion import(GO:0010107) |
0.8 | 6.9 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.8 | 2.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.8 | 16.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.8 | 18.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.8 | 9.8 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 4.5 | GO:0015816 | glycine transport(GO:0015816) |
0.8 | 6.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.8 | 3.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.8 | 7.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.8 | 2.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.7 | 10.5 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.7 | 14.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.7 | 33.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.7 | 9.0 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.7 | 4.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.7 | 8.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 1.5 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.7 | 1.5 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.7 | 2.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.7 | 2.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.7 | 14.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.7 | 2.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.7 | 2.2 | GO:1903347 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
0.7 | 5.8 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.7 | 2.2 | GO:0035483 | negative regulation of sodium:proton antiporter activity(GO:0032416) gastric motility(GO:0035482) gastric emptying(GO:0035483) musculoskeletal movement, spinal reflex action(GO:0050883) |
0.7 | 12.2 | GO:0009299 | mRNA transcription(GO:0009299) |
0.7 | 3.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.7 | 3.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.7 | 7.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.7 | 43.4 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.7 | 5.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.7 | 3.5 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.7 | 16.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.7 | 4.9 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.7 | 2.8 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.7 | 3.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.7 | 1.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.7 | 5.5 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.7 | 2.7 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.7 | 2.0 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.7 | 9.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.7 | 1.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.7 | 4.7 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.7 | 6.7 | GO:0051014 | actin filament severing(GO:0051014) |
0.7 | 4.0 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.7 | 4.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.7 | 1.3 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 1.3 | GO:0002507 | tolerance induction(GO:0002507) |
0.7 | 1.3 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.7 | 12.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.7 | 6.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.7 | 6.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.7 | 3.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.7 | 19.8 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.7 | 4.6 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 1.3 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.7 | 10.5 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.7 | 1.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
0.7 | 2.6 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.7 | 11.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.6 | 5.1 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.6 | 3.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.6 | 1.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.6 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.6 | 5.1 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.6 | 1.9 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.6 | 3.8 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 5.7 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.6 | 1.3 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.6 | 9.5 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.6 | 3.1 | GO:0033058 | directional locomotion(GO:0033058) |
0.6 | 4.4 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.6 | 3.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) cardiolipin acyl-chain remodeling(GO:0035965) |
0.6 | 8.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.6 | 2.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.6 | 3.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.6 | 4.3 | GO:0007143 | female meiotic division(GO:0007143) |
0.6 | 10.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.6 | 1.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.6 | 4.2 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.6 | 4.2 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 4.2 | GO:1903003 | regulation of protein deubiquitination(GO:0090085) positive regulation of protein deubiquitination(GO:1903003) |
0.6 | 3.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.6 | 4.2 | GO:0080009 | mRNA methylation(GO:0080009) |
0.6 | 5.4 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.6 | 44.1 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.6 | 4.1 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.6 | 18.7 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.6 | 2.3 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.6 | 4.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.6 | 2.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of metalloendopeptidase activity(GO:1904683) |
0.6 | 4.6 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.6 | 6.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 8.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.6 | 2.3 | GO:0060039 | pericardium development(GO:0060039) |
0.6 | 5.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 10.2 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) |
0.6 | 1.1 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.6 | 1.7 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
0.6 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.6 | 2.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.6 | 1.7 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.6 | 2.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.6 | 8.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.6 | 2.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 6.1 | GO:0030238 | male sex determination(GO:0030238) |
0.6 | 2.8 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.6 | 2.8 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.6 | 1.7 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.6 | 0.6 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.5 | 2.2 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.5 | 8.1 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.5 | 3.8 | GO:0061709 | reticulophagy(GO:0061709) |
0.5 | 6.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.5 | 5.4 | GO:0039536 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) negative regulation of RIG-I signaling pathway(GO:0039536) |
0.5 | 3.8 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.5 | 1.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.5 | 1.1 | GO:0035564 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) |
0.5 | 1.6 | GO:2000706 | dense core granule biogenesis(GO:0061110) amniotic stem cell differentiation(GO:0097086) regulation of dense core granule biogenesis(GO:2000705) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
0.5 | 0.5 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.5 | 2.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.5 | 33.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.5 | 5.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.5 | 10.4 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.5 | 3.6 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.5 | 2.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.5 | 2.0 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.5 | 10.2 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.5 | 10.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.5 | 4.0 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.5 | 2.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.5 | 1.0 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.5 | 6.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 2.0 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.5 | 1.0 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.5 | 16.7 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.5 | 2.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.5 | 2.4 | GO:0072553 | terminal button organization(GO:0072553) |
0.5 | 12.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.5 | 1.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 6.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 1.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.5 | 1.9 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.5 | 6.6 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.5 | 5.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 3.8 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.5 | 2.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.5 | 0.9 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.5 | 5.2 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.5 | 2.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.5 | 3.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.5 | 3.7 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.5 | 1.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.4 | 0.9 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.4 | 1.8 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.4 | 6.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.4 | 2.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.4 | 2.2 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.4 | 1.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.4 | 2.2 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.4 | 4.4 | GO:0051923 | sulfation(GO:0051923) |
0.4 | 2.2 | GO:0030903 | notochord development(GO:0030903) |
0.4 | 10.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.4 | 1.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.4 | 1.3 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.4 | 5.1 | GO:0032094 | response to food(GO:0032094) |
0.4 | 0.8 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.4 | 1.7 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.4 | 5.1 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.4 | 3.0 | GO:0018342 | protein prenylation(GO:0018342) protein geranylgeranylation(GO:0018344) prenylation(GO:0097354) |
0.4 | 2.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.4 | 12.8 | GO:0031641 | regulation of myelination(GO:0031641) |
0.4 | 2.1 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.4 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.4 | 0.8 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.4 | 0.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.4 | 2.4 | GO:0022605 | ovarian cumulus expansion(GO:0001550) oogenesis stage(GO:0022605) fused antrum stage(GO:0048165) |
0.4 | 1.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.4 | 1.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 5.2 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.4 | 2.8 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.4 | 5.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.4 | 4.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.4 | 3.9 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.4 | 1.2 | GO:0019605 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
0.4 | 2.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.4 | 2.7 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.4 | 126.0 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.4 | 2.3 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 2.3 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 3.8 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.4 | 1.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 7.2 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 1.1 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.4 | 3.3 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.4 | 1.5 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.4 | 2.6 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.4 | 21.2 | GO:0038096 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.4 | 9.3 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.4 | 7.1 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.4 | 4.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.4 | 1.8 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.3 | 3.5 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.3 | 1.4 | GO:0015813 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.3 | 2.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.3 | 11.1 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.3 | 8.3 | GO:0015698 | inorganic anion transport(GO:0015698) |
0.3 | 3.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.3 | 33.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.3 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 4.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 2.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 11.2 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.3 | 4.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 3.5 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 2.6 | GO:0045124 | regulation of bone resorption(GO:0045124) |
0.3 | 1.0 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 1.9 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 3.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.3 | 1.2 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
0.3 | 1.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.3 | 4.0 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.3 | 3.0 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
0.3 | 3.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.3 | 3.0 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 5.7 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.3 | 2.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.3 | 5.1 | GO:0007140 | male meiosis(GO:0007140) |
0.3 | 4.1 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 1.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.3 | 2.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.3 | 1.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.3 | 3.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 3.6 | GO:1900744 | regulation of p38MAPK cascade(GO:1900744) |
0.3 | 0.5 | GO:0001659 | temperature homeostasis(GO:0001659) |
0.3 | 3.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 3.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.3 | 0.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 0.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.3 | 13.5 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.3 | 6.4 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.3 | 1.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.3 | 7.7 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.2 | 13.7 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.2 | 0.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 2.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.2 | 1.0 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.2 | 0.7 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.2 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.2 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 1.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 1.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.2 | 4.8 | GO:0046849 | bone remodeling(GO:0046849) |
0.2 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 0.7 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.2 | 0.9 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 7.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.2 | 0.9 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 4.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.2 | 6.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.2 | 3.7 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.2 | 1.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.2 | 0.8 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 1.4 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.2 | 1.2 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.2 | 0.4 | GO:1901018 | positive regulation of potassium ion transmembrane transporter activity(GO:1901018) |
0.2 | 3.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.2 | 1.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 2.3 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 1.1 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 1.3 | GO:0072319 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
0.2 | 0.4 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 3.6 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 1.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.7 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.2 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.2 | 1.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.9 | GO:0042417 | dopamine metabolic process(GO:0042417) |
0.2 | 18.5 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.2 | 0.3 | GO:0072313 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 2.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.5 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 1.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.9 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.1 | 2.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.7 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 1.0 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.4 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) peripheral nervous system neuron axonogenesis(GO:0048936) |
0.1 | 2.3 | GO:0048753 | pigment granule organization(GO:0048753) |
0.1 | 0.9 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.9 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.5 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 2.0 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.1 | 0.9 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.5 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.1 | 0.1 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.5 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.1 | 4.8 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.2 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.1 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.0 | 0.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.0 | 0.2 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.2 | GO:0030043 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) actin filament fragmentation(GO:0030043) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.0 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.2 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.0 | 1.0 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.1 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
0.0 | 0.8 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.4 | GO:0001947 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) |
0.0 | 0.1 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.0 | 0.2 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.0 | 0.1 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.0 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.0 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
27.7 | 27.7 | GO:0071753 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
24.8 | 149.0 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
20.6 | 82.4 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
19.0 | 913.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
17.9 | 340.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
12.0 | 132.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
8.8 | 26.3 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
8.5 | 33.9 | GO:0005602 | complement component C1 complex(GO:0005602) |
7.4 | 52.0 | GO:0032010 | phagolysosome(GO:0032010) |
7.4 | 7.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
7.1 | 35.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
7.1 | 42.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
6.8 | 74.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
5.9 | 29.5 | GO:0036398 | TCR signalosome(GO:0036398) |
5.9 | 64.8 | GO:0060171 | stereocilium membrane(GO:0060171) |
5.1 | 15.3 | GO:0070701 | mucus layer(GO:0070701) |
5.0 | 15.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
5.0 | 29.8 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
5.0 | 24.9 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
4.9 | 24.7 | GO:1990031 | pinceau fiber(GO:1990031) |
4.9 | 29.2 | GO:0044194 | cytolytic granule(GO:0044194) |
4.7 | 18.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.5 | 63.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
4.2 | 71.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
4.2 | 25.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
4.1 | 77.8 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
4.0 | 15.9 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
4.0 | 98.9 | GO:0001891 | phagocytic cup(GO:0001891) |
3.9 | 15.7 | GO:0071546 | pi-body(GO:0071546) |
3.8 | 15.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
3.5 | 46.1 | GO:0005833 | hemoglobin complex(GO:0005833) |
3.4 | 65.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
3.3 | 63.6 | GO:0042629 | mast cell granule(GO:0042629) |
3.2 | 15.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.2 | 19.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
3.1 | 15.7 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
3.1 | 12.5 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
3.1 | 21.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
2.9 | 5.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
2.8 | 33.8 | GO:0097486 | multivesicular body lumen(GO:0097486) |
2.8 | 2.8 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
2.7 | 10.8 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.7 | 37.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.7 | 8.0 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
2.6 | 23.8 | GO:0071953 | elastic fiber(GO:0071953) |
2.6 | 10.5 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.6 | 142.2 | GO:0001772 | immunological synapse(GO:0001772) |
2.6 | 12.9 | GO:0001652 | granular component(GO:0001652) |
2.4 | 12.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
2.4 | 19.5 | GO:0035976 | AP1 complex(GO:0035976) |
2.4 | 17.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.4 | 4.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.3 | 53.5 | GO:0042627 | chylomicron(GO:0042627) |
2.3 | 16.2 | GO:0033391 | chromatoid body(GO:0033391) |
2.2 | 4.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
2.2 | 8.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.1 | 12.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
2.1 | 313.2 | GO:0072562 | blood microparticle(GO:0072562) |
2.1 | 6.2 | GO:0000805 | X chromosome(GO:0000805) |
2.1 | 33.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
2.0 | 14.3 | GO:1990745 | EARP complex(GO:1990745) |
2.0 | 18.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
2.0 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
2.0 | 5.9 | GO:0031251 | PAN complex(GO:0031251) |
1.9 | 13.5 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
1.9 | 69.2 | GO:0008305 | integrin complex(GO:0008305) |
1.9 | 17.1 | GO:0070652 | HAUS complex(GO:0070652) |
1.8 | 11.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.8 | 10.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.8 | 5.4 | GO:0033263 | CORVET complex(GO:0033263) |
1.8 | 7.1 | GO:0070876 | SOSS complex(GO:0070876) |
1.8 | 5.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.7 | 10.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.7 | 8.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
1.7 | 57.9 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
1.7 | 5.0 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
1.6 | 6.6 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
1.6 | 159.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
1.6 | 6.5 | GO:1990879 | CST complex(GO:1990879) |
1.6 | 19.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.6 | 9.4 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.5 | 4.6 | GO:0030312 | external encapsulating structure(GO:0030312) |
1.5 | 187.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
1.5 | 3.0 | GO:0032797 | SMN complex(GO:0032797) |
1.5 | 13.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.5 | 37.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.5 | 7.3 | GO:0034464 | BBSome(GO:0034464) |
1.4 | 10.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
1.4 | 7.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.4 | 14.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.4 | 7.0 | GO:0032302 | MutSbeta complex(GO:0032302) |
1.4 | 24.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.4 | 11.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.4 | 20.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.4 | 5.5 | GO:0000801 | central element(GO:0000801) |
1.4 | 13.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.3 | 10.7 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
1.3 | 9.2 | GO:0072687 | meiotic spindle(GO:0072687) |
1.3 | 11.5 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
1.3 | 44.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
1.3 | 7.6 | GO:0070545 | PeBoW complex(GO:0070545) |
1.3 | 2.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
1.3 | 7.5 | GO:0032584 | growth cone membrane(GO:0032584) |
1.3 | 6.3 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 6.2 | GO:0089701 | U2AF(GO:0089701) |
1.2 | 3.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.2 | 56.8 | GO:0001533 | cornified envelope(GO:0001533) |
1.2 | 4.9 | GO:0097443 | sorting endosome(GO:0097443) |
1.2 | 9.8 | GO:0043203 | axon hillock(GO:0043203) |
1.2 | 15.6 | GO:0097413 | Lewy body(GO:0097413) |
1.2 | 3.6 | GO:0032590 | dendrite membrane(GO:0032590) |
1.2 | 4.7 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
1.2 | 11.7 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
1.2 | 5.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
1.2 | 22.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
1.2 | 41.7 | GO:0034451 | centriolar satellite(GO:0034451) |
1.2 | 5.8 | GO:0045179 | apical cortex(GO:0045179) |
1.1 | 17.0 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.1 | 4.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.1 | 4.5 | GO:0031905 | early endosome lumen(GO:0031905) |
1.1 | 3.3 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
1.1 | 4.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
1.1 | 2.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.1 | 6.5 | GO:0044327 | dendritic spine head(GO:0044327) |
1.1 | 48.2 | GO:0016235 | aggresome(GO:0016235) |
1.1 | 17.0 | GO:0031904 | endosome lumen(GO:0031904) |
1.0 | 119.9 | GO:0005796 | Golgi lumen(GO:0005796) |
1.0 | 3.1 | GO:0034657 | GID complex(GO:0034657) |
1.0 | 1.0 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
1.0 | 4.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
1.0 | 5.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
1.0 | 3.0 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
1.0 | 3.0 | GO:0097165 | nuclear stress granule(GO:0097165) |
1.0 | 4.9 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
1.0 | 8.7 | GO:0032059 | bleb(GO:0032059) |
1.0 | 70.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
1.0 | 5.8 | GO:0005594 | collagen type IX trimer(GO:0005594) |
1.0 | 68.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.9 | 13.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.9 | 37.7 | GO:0016592 | mediator complex(GO:0016592) |
0.9 | 5.6 | GO:0002177 | manchette(GO:0002177) |
0.9 | 3.7 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.9 | 4.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.9 | 5.4 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.9 | 15.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.9 | 2.7 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.9 | 2.6 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.9 | 4.4 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
0.9 | 2.6 | GO:0099569 | cytoskeleton of presynaptic active zone(GO:0048788) presynaptic active zone cytoplasmic component(GO:0098831) presynaptic cytoskeleton(GO:0099569) |
0.9 | 0.9 | GO:0014802 | terminal cisterna(GO:0014802) |
0.9 | 2.6 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.8 | 15.1 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 25.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.8 | 2.5 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.8 | 2.5 | GO:0098536 | deuterosome(GO:0098536) |
0.8 | 5.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.8 | 3.2 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.8 | 20.1 | GO:0032982 | myosin filament(GO:0032982) |
0.8 | 15.7 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.8 | 3.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 4.6 | GO:0097452 | GAIT complex(GO:0097452) |
0.8 | 3.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.7 | 3.0 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 179.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.7 | 3.0 | GO:0044307 | dendritic branch(GO:0044307) |
0.7 | 2.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 8.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.7 | 3.7 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.7 | 5.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.7 | 3.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.7 | 10.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.7 | 2.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.7 | 5.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.7 | 2.0 | GO:0005745 | m-AAA complex(GO:0005745) |
0.7 | 7.4 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.7 | 3.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.6 | 28.6 | GO:0035579 | specific granule membrane(GO:0035579) |
0.6 | 10.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.6 | 16.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.6 | 2.5 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 1.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 5.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 10.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.6 | 9.7 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 3.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.6 | 2.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.6 | 1.8 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 65.8 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.6 | 8.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 2.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.6 | 8.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.6 | 3.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 2.2 | GO:0035363 | histone locus body(GO:0035363) |
0.6 | 2.8 | GO:0036157 | outer dynein arm(GO:0036157) |
0.6 | 39.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 2.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.6 | 2.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.6 | 31.4 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 642.5 | GO:0005615 | extracellular space(GO:0005615) |
0.5 | 1.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.5 | 3.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.5 | 3.7 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 1.5 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
0.5 | 5.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.5 | 4.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.5 | 11.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.5 | 5.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.5 | 49.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.5 | 11.0 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.5 | 14.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.5 | 2.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.5 | 4.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.4 | 2.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 1.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.4 | 3.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 6.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 5.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.4 | 1.7 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 74.5 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.4 | 15.6 | GO:0005902 | microvillus(GO:0005902) |
0.4 | 5.0 | GO:0016013 | syntrophin complex(GO:0016013) |
0.4 | 5.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.4 | 2.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.4 | 2.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.4 | 8.0 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.4 | 8.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.4 | 2.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.4 | 2.3 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.4 | 1.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.4 | 3.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.4 | 1.8 | GO:0071565 | nBAF complex(GO:0071565) |
0.3 | 1.7 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.3 | 43.2 | GO:0016605 | PML body(GO:0016605) |
0.3 | 6.2 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 23.5 | GO:0005814 | centriole(GO:0005814) |
0.3 | 4.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.3 | 3.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 3.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 23.7 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 3.9 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 5.9 | GO:0097546 | ciliary base(GO:0097546) |
0.3 | 36.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.9 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.8 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 7.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.2 | 3.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.2 | 2.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.2 | 1.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 1.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 5.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 11.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.2 | 0.8 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.2 | 0.6 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.2 | 10.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 1.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.2 | 2.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.5 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 1.8 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 3.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 4.2 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.2 | 7.1 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.2 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 2.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 8.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 9.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.7 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 329.8 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
0.1 | 0.2 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.0 | 0.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.0 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.0 | 0.1 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.7 | 98.7 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
21.9 | 153.3 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
19.2 | 57.7 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
17.1 | 51.3 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
17.0 | 1018.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
16.7 | 150.2 | GO:0043426 | MRF binding(GO:0043426) |
12.5 | 50.1 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
12.1 | 460.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
11.7 | 58.6 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
10.4 | 83.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
10.1 | 30.3 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
10.0 | 39.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
9.0 | 36.2 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
8.9 | 26.8 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
8.5 | 119.4 | GO:0019864 | IgG binding(GO:0019864) |
8.1 | 40.4 | GO:0042610 | CD8 receptor binding(GO:0042610) |
8.1 | 32.3 | GO:0004341 | gluconolactonase activity(GO:0004341) |
7.7 | 23.2 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
7.6 | 22.9 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
7.6 | 30.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
7.5 | 30.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
7.4 | 7.4 | GO:0001851 | complement component C3b binding(GO:0001851) |
6.3 | 19.0 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
6.3 | 19.0 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
6.2 | 50.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
6.1 | 892.8 | GO:0003823 | antigen binding(GO:0003823) |
6.0 | 54.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
6.0 | 18.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
5.9 | 17.8 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
5.9 | 29.5 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
5.7 | 22.8 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
5.6 | 33.7 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
5.3 | 21.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
5.3 | 15.9 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
5.2 | 31.5 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
5.2 | 77.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
5.2 | 31.0 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
5.1 | 15.4 | GO:0033749 | histone demethylase activity (H3-R2 specific)(GO:0033746) histone demethylase activity (H4-R3 specific)(GO:0033749) |
5.1 | 20.5 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
4.9 | 24.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.8 | 14.3 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
4.7 | 28.4 | GO:0030172 | troponin C binding(GO:0030172) |
4.7 | 14.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
4.7 | 14.0 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
4.6 | 37.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
4.5 | 22.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
4.4 | 17.7 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
4.2 | 12.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
4.2 | 21.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.2 | 12.6 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
4.2 | 20.9 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
4.1 | 20.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
4.0 | 63.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
3.8 | 11.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
3.8 | 22.6 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
3.7 | 18.6 | GO:0004803 | transposase activity(GO:0004803) |
3.6 | 10.9 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
3.6 | 47.2 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
3.6 | 21.8 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
3.6 | 43.0 | GO:0008430 | selenium binding(GO:0008430) |
3.6 | 28.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
3.5 | 42.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
3.5 | 24.3 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
3.5 | 3.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
3.4 | 17.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
3.4 | 20.2 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
3.4 | 30.2 | GO:0004875 | complement receptor activity(GO:0004875) |
3.3 | 10.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
3.2 | 9.7 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
3.2 | 32.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
3.2 | 9.6 | GO:0016497 | substance K receptor activity(GO:0016497) |
3.1 | 18.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
3.1 | 12.3 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
3.1 | 12.2 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
3.0 | 6.1 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
3.0 | 12.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
3.0 | 6.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.9 | 14.6 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
2.9 | 11.6 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
2.9 | 40.7 | GO:0031419 | cobalamin binding(GO:0031419) |
2.9 | 11.5 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
2.8 | 14.2 | GO:0004522 | ribonuclease A activity(GO:0004522) |
2.8 | 8.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
2.8 | 39.4 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
2.8 | 103.3 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
2.7 | 16.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
2.7 | 8.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
2.7 | 8.1 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
2.7 | 8.1 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
2.7 | 2.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
2.6 | 7.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
2.6 | 2.6 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
2.5 | 7.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
2.5 | 10.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
2.5 | 15.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
2.5 | 19.8 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
2.5 | 14.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
2.4 | 7.3 | GO:0016936 | galactoside binding(GO:0016936) |
2.4 | 26.6 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.4 | 7.2 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
2.4 | 14.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
2.4 | 12.0 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
2.4 | 14.3 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
2.4 | 4.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
2.4 | 21.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
2.4 | 16.6 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
2.4 | 7.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
2.3 | 9.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
2.3 | 7.0 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
2.3 | 9.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
2.3 | 11.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
2.3 | 6.9 | GO:0035473 | lipase binding(GO:0035473) |
2.3 | 16.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.3 | 6.9 | GO:0048030 | disaccharide binding(GO:0048030) |
2.3 | 6.9 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
2.3 | 6.9 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
2.3 | 6.9 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
2.3 | 22.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
2.3 | 20.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
2.2 | 15.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
2.2 | 6.7 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
2.2 | 11.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
2.2 | 8.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
2.2 | 2.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
2.2 | 6.6 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
2.2 | 6.6 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
2.2 | 23.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
2.1 | 21.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
2.1 | 8.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
2.1 | 10.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
2.1 | 18.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
2.0 | 79.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
2.0 | 8.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
2.0 | 14.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.0 | 9.9 | GO:0003796 | lysozyme activity(GO:0003796) |
2.0 | 5.9 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
2.0 | 15.8 | GO:0098821 | BMP receptor activity(GO:0098821) |
2.0 | 7.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
1.9 | 5.8 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
1.9 | 13.6 | GO:0019863 | IgE binding(GO:0019863) |
1.9 | 5.8 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
1.9 | 21.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.9 | 5.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
1.9 | 20.8 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
1.9 | 7.5 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
1.9 | 5.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.8 | 7.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.8 | 12.9 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.8 | 7.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.8 | 5.5 | GO:0017129 | triglyceride binding(GO:0017129) |
1.8 | 27.0 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.8 | 1.8 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
1.8 | 5.4 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
1.8 | 1.8 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
1.8 | 56.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
1.8 | 5.3 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
1.8 | 5.3 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
1.8 | 7.0 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
1.8 | 24.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.8 | 35.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.7 | 7.0 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
1.7 | 7.0 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.7 | 43.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
1.7 | 8.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.7 | 8.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.7 | 17.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.7 | 15.3 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.7 | 5.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
1.7 | 5.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
1.7 | 5.1 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
1.7 | 15.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
1.7 | 10.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.7 | 6.7 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.7 | 30.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.7 | 11.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.7 | 371.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.6 | 6.6 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
1.6 | 1.6 | GO:0046978 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) |
1.6 | 8.2 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.6 | 9.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.6 | 6.4 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
1.6 | 3.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.6 | 12.7 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
1.6 | 29.9 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.6 | 11.0 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
1.6 | 17.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.6 | 14.0 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.6 | 6.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
1.6 | 4.7 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
1.6 | 4.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
1.5 | 21.7 | GO:0045159 | myosin II binding(GO:0045159) |
1.5 | 24.8 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 7.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
1.5 | 4.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.5 | 7.6 | GO:0050436 | microfibril binding(GO:0050436) |
1.5 | 7.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
1.5 | 4.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
1.5 | 8.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.5 | 4.5 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
1.5 | 14.9 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
1.5 | 13.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.5 | 10.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
1.4 | 11.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
1.4 | 10.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.4 | 8.4 | GO:0022821 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
1.4 | 19.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
1.4 | 5.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.4 | 2.8 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.4 | 4.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
1.4 | 8.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.4 | 5.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.4 | 4.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.4 | 17.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
1.3 | 9.4 | GO:0030911 | TPR domain binding(GO:0030911) |
1.3 | 6.7 | GO:0003909 | DNA ligase activity(GO:0003909) |
1.3 | 25.3 | GO:0038191 | neuropilin binding(GO:0038191) |
1.3 | 5.3 | GO:0045569 | TRAIL binding(GO:0045569) |
1.3 | 38.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
1.3 | 3.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
1.3 | 10.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.3 | 15.6 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.3 | 3.9 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.3 | 5.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
1.3 | 7.7 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
1.3 | 6.4 | GO:0016160 | amylase activity(GO:0016160) |
1.3 | 5.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 5.0 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.3 | 10.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.2 | 9.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.2 | 100.6 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.2 | 4.9 | GO:0004079 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
1.2 | 18.5 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
1.2 | 9.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
1.2 | 3.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.2 | 3.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.2 | 10.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.2 | 8.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
1.2 | 6.0 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
1.2 | 30.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.2 | 2.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.2 | 4.7 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.2 | 3.5 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
1.2 | 4.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
1.2 | 39.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
1.1 | 4.6 | GO:0002046 | opsin binding(GO:0002046) |
1.1 | 2.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
1.1 | 5.7 | GO:1990254 | keratin filament binding(GO:1990254) |
1.1 | 6.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
1.1 | 3.4 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
1.1 | 59.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 7.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.1 | 10.0 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
1.1 | 3.3 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
1.1 | 4.4 | GO:0047298 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
1.1 | 5.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.1 | 6.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
1.1 | 5.5 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.1 | 5.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
1.1 | 3.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
1.1 | 19.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.1 | 10.9 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 31.6 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
1.1 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 3.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
1.1 | 25.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.1 | 8.4 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
1.0 | 7.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.0 | 3.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
1.0 | 6.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.0 | 2.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
1.0 | 1.0 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
1.0 | 42.3 | GO:0030332 | cyclin binding(GO:0030332) |
1.0 | 17.1 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
1.0 | 59.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
1.0 | 10.9 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.0 | 4.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.0 | 3.0 | GO:0008431 | vitamin E binding(GO:0008431) |
1.0 | 3.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.0 | 6.9 | GO:0001515 | opioid peptide activity(GO:0001515) |
1.0 | 3.9 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
1.0 | 3.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
1.0 | 5.9 | GO:0070728 | leucine binding(GO:0070728) |
1.0 | 3.9 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
1.0 | 3.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
1.0 | 10.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
1.0 | 2.9 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.9 | 26.5 | GO:0071949 | FAD binding(GO:0071949) |
0.9 | 3.7 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.9 | 2.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.9 | 6.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.9 | 6.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.9 | 8.2 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.9 | 1.8 | GO:0032427 | GBD domain binding(GO:0032427) |
0.9 | 18.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.9 | 2.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.9 | 4.4 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.9 | 4.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.9 | 18.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.9 | 3.5 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.9 | 13.2 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.9 | 12.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 17.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.9 | 4.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.9 | 7.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.9 | 2.6 | GO:0030290 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
0.9 | 13.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 12.8 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.8 | 6.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.8 | 2.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.8 | 9.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.8 | 5.8 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.8 | 4.9 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.8 | 4.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.8 | 2.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.8 | 3.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.8 | 6.5 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.8 | 8.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 278.0 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.8 | 9.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.8 | 6.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.8 | 2.4 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.8 | 3.1 | GO:0001031 | RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
0.8 | 3.1 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.8 | 15.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.8 | 14.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.8 | 2.3 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.8 | 15.3 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 8.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.8 | 6.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.8 | 6.1 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.8 | 7.5 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.8 | 15.0 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.7 | 9.0 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.7 | 72.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.7 | 2.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.7 | 5.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.7 | 1.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.7 | 7.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.7 | 3.7 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.7 | 2.9 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.7 | 15.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.7 | 8.6 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.7 | 4.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.7 | 8.6 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 24.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.7 | 9.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.7 | 43.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.7 | 7.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.7 | 4.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.7 | 3.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.7 | 3.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.7 | 6.2 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.7 | 4.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.7 | 8.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.7 | 8.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.7 | 12.8 | GO:0048156 | tau protein binding(GO:0048156) |
0.7 | 4.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.7 | 18.1 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.7 | 5.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.7 | 7.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.7 | 12.5 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.7 | 2.0 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.7 | 2.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 3.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 10.3 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.6 | 16.1 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.6 | 3.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.6 | 1.9 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
0.6 | 120.0 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.6 | 2.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.6 | 17.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
0.6 | 2.5 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.6 | 7.4 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.6 | 2.5 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.6 | 6.1 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 3.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.6 | 7.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 3.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 9.1 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.6 | 12.7 | GO:0031005 | filamin binding(GO:0031005) |
0.6 | 4.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.6 | 11.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.6 | 13.0 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 3.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.6 | 9.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.6 | 6.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.6 | 2.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.6 | 1.7 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.6 | 2.3 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.6 | 1.7 | GO:0031711 | angiotensin type I receptor activity(GO:0001596) bradykinin receptor binding(GO:0031711) |
0.6 | 2.2 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.6 | 3.9 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.6 | 2.2 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.6 | 5.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.6 | 10.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.6 | 1.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.5 | 2.7 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.5 | 11.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.5 | 26.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 12.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 61.1 | GO:0005179 | hormone activity(GO:0005179) |
0.5 | 10.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 12.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.5 | 2.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.5 | 1.6 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.5 | 2.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 6.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.5 | 1.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.5 | 1.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.5 | 4.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.5 | 29.4 | GO:0043621 | protein self-association(GO:0043621) |
0.5 | 1.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.5 | 11.5 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.5 | 14.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.5 | 6.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 9.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.5 | 1.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 5.3 | GO:0015643 | toxic substance binding(GO:0015643) |
0.5 | 1.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 1.0 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.5 | 6.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 2.8 | GO:0004359 | glutaminase activity(GO:0004359) |
0.5 | 11.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.5 | 3.2 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.5 | 7.4 | GO:0016594 | glycine binding(GO:0016594) |
0.5 | 8.3 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.5 | 6.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.4 | 1.8 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.4 | 2.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.4 | 4.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.4 | 11.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.4 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 0.9 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 1.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.4 | 2.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.4 | 5.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.4 | 8.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.4 | 1.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.4 | 1.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 4.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 2.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.4 | 5.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.4 | 0.8 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.4 | 10.5 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.4 | 3.6 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.4 | 1.6 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
0.4 | 1.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.4 | 3.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 0.4 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.4 | 5.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.4 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.4 | 7.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.4 | 1.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.4 | 2.6 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.4 | 4.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.4 | 6.3 | GO:0001614 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 24.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.4 | 4.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.4 | 20.2 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
0.4 | 4.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.4 | 2.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 0.7 | GO:0004040 | amidase activity(GO:0004040) |
0.4 | 1.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.4 | 14.2 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.4 | 58.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 1.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.3 | 30.3 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 3.7 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.3 | 33.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.3 | 5.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.3 | 1.7 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 4.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.3 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.3 | 1.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.3 | 2.3 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 6.1 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 7.9 | GO:0032451 | demethylase activity(GO:0032451) |
0.3 | 5.1 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 11.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.3 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 3.4 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 7.7 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.3 | 1.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 4.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 0.9 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.3 | 0.6 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.3 | 1.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.3 | 2.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.3 | 354.3 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.3 | 13.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 1.1 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.3 | 4.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.3 | 5.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.3 | 18.9 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
0.3 | 1.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 1.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 4.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 1.2 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 22.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.7 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
0.2 | 2.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.2 | 1.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.2 | 35.4 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
0.2 | 3.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.7 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.2 | 0.7 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 0.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 0.4 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.2 | 4.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 1.8 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.2 | 0.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
0.2 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 26.3 | GO:0005516 | calmodulin binding(GO:0005516) |
0.2 | 3.7 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.2 | 0.8 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.2 | 0.6 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.2 | 1.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.6 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.2 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.2 | 9.7 | GO:0005254 | chloride channel activity(GO:0005254) |
0.2 | 0.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.2 | 2.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 2.3 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.2 | 0.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.2 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 0.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 4.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.7 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 2.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 1.9 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.4 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.8 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.1 | 4.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 3.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.1 | 0.5 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.5 | GO:0019826 | oxygen sensor activity(GO:0019826) |
0.1 | 0.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 9.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 1.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 1.1 | GO:0099589 | serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.4 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 3.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 0.7 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 2.5 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
0.1 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 0.4 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.7 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 1.5 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 1.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 3.1 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.2 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 1.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 2.8 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.4 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.0 | 1.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.0 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 344.1 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
5.2 | 15.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
4.4 | 13.2 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
3.7 | 324.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
3.5 | 10.6 | PID S1P S1P4 PATHWAY | S1P4 pathway |
3.4 | 325.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
3.3 | 6.6 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.6 | 23.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
2.4 | 29.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
2.4 | 7.1 | ST STAT3 PATHWAY | STAT3 Pathway |
2.2 | 32.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.1 | 51.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.0 | 27.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.8 | 29.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.8 | 77.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.7 | 106.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
1.7 | 6.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.7 | 17.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.7 | 13.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
1.6 | 6.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
1.6 | 1.6 | ST GAQ PATHWAY | G alpha q Pathway |
1.5 | 47.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.5 | 3.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
1.5 | 10.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.5 | 37.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
1.5 | 7.4 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.5 | 56.6 | PID BCR 5PATHWAY | BCR signaling pathway |
1.4 | 15.8 | PID ALK1 PATHWAY | ALK1 signaling events |
1.4 | 12.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
1.4 | 19.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
1.4 | 9.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.4 | 73.0 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.3 | 12.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
1.2 | 41.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.2 | 82.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.0 | 51.4 | PID ARF6 PATHWAY | Arf6 signaling events |
1.0 | 44.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
1.0 | 13.4 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 35.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.9 | 20.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.9 | 17.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.9 | 2.7 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.9 | 14.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 149.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.8 | 15.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.8 | 4.1 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.8 | 26.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.8 | 8.1 | PID EPO PATHWAY | EPO signaling pathway |
0.8 | 19.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.7 | 14.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.7 | 8.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.7 | 12.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 16.2 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.7 | 16.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 3.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.6 | 5.8 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.6 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.6 | 15.3 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 2.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.6 | 25.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.6 | 23.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 17.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 5.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.5 | 35.0 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.5 | 132.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 8.0 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.5 | 32.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.5 | 33.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.5 | 1.0 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.5 | 29.0 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 12.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.5 | 7.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.5 | 2.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.5 | 25.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.4 | 2.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 8.2 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 14.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.4 | 0.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.4 | 3.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 6.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.4 | 3.8 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.4 | 22.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.4 | 7.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.4 | 28.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 4.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 18.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.3 | 2.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.3 | 8.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 9.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 1.6 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 31.8 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 12.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.3 | 2.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.3 | 4.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.2 | 20.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 14.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.2 | 1.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 10.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 1.0 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 4.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 2.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 2.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 5.7 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.2 | 7.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 7.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 0.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 43.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 2.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 3.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 4.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 5.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 5.8 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 3.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 0.9 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 384.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
11.2 | 123.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
10.5 | 73.7 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
6.8 | 13.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
5.5 | 27.3 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
5.3 | 457.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
3.6 | 7.2 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
3.2 | 6.4 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
3.2 | 6.4 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
3.1 | 55.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
2.7 | 53.8 | REACTOME DEFENSINS | Genes involved in Defensins |
2.6 | 49.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.6 | 36.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
2.4 | 35.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
2.4 | 58.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
2.2 | 10.9 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
2.1 | 33.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
2.0 | 26.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
1.9 | 28.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.8 | 24.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
1.8 | 3.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
1.8 | 42.4 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.7 | 5.1 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
1.6 | 70.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
1.6 | 3.3 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
1.6 | 4.7 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.6 | 20.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.5 | 7.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.5 | 6.1 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.5 | 48.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.5 | 26.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.5 | 45.2 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
1.5 | 8.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.4 | 5.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
1.4 | 15.8 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.4 | 32.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.4 | 14.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
1.4 | 63.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
1.3 | 80.3 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
1.3 | 21.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
1.3 | 29.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.3 | 55.8 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.3 | 27.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.3 | 33.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
1.2 | 12.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.1 | 29.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.1 | 9.1 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
1.1 | 9.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
1.1 | 10.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.1 | 18.2 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.1 | 8.6 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.1 | 22.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.0 | 25.8 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.0 | 59.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.0 | 21.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.0 | 7.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.0 | 3.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.0 | 33.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.9 | 5.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.9 | 4.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.9 | 4.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.9 | 3.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.9 | 16.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.9 | 4.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.9 | 34.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.9 | 14.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 38.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 21.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.8 | 24.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.8 | 31.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.8 | 8.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.8 | 40.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 7.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.8 | 73.1 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.8 | 11.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.8 | 6.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.8 | 4.5 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.8 | 9.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.7 | 11.0 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.7 | 11.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 32.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.7 | 9.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.7 | 15.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.7 | 305.9 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.7 | 7.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.7 | 6.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.7 | 10.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.7 | 16.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.7 | 28.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.6 | 36.3 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.6 | 90.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.6 | 4.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.6 | 3.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 11.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 13.0 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.6 | 5.9 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 15.1 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.5 | 6.0 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 20.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.5 | 3.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.5 | 92.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.5 | 10.6 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.5 | 65.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.5 | 3.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.5 | 10.7 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.5 | 12.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.5 | 9.7 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 13.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.4 | 31.0 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.4 | 4.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 21.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 8.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.4 | 13.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.4 | 5.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 9.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 5.9 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.4 | 29.8 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.4 | 2.6 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.4 | 7.4 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.4 | 31.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.3 | 5.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 6.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 10.6 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 1.0 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 21.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.3 | 1.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.3 | 4.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 9.5 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
0.3 | 13.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 5.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 9.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 2.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 5.4 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.2 | 8.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 1.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 2.7 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 1.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.2 | 5.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 1.8 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.2 | 1.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 3.6 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.2 | 3.8 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.2 | 3.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.2 | 0.7 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.2 | 4.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 2.4 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 1.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 0.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 3.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.1 | 1.5 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 2.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 8.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 14.0 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.1 | 0.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 4.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 6.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.1 | 0.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.6 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.1 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 3.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.8 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |